Global Clinical Head-MASH (Boston)

At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality! If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you’re our kind of person.

We are hiring a Global Clinical Head (GCH) for MASH in our Late Cardiovascular, Renal and Metabolism (CVRM) Global Development team.  This is a key role where you, with your strong leadership skills and drug development experience, will impact and drive development programs in a dynamic global setting.  This role reports to the Vice President, Clinical Metabolism and is based in Boston, MA.

What you’ll do:

The GCH is the most senior medical scientific authority on an asset team and is a core member of the Global Product Team (GPT). The GCH is accountable for all clinical and scientific aspects of the asset(s), including benefit/risk assessment, scientific strategies for clinical components of the Target Product Profile (TPP), Target Product Claim (TPC), Clinical Development Plan (CDP), and core labelling. The GCH develops the project strategy in partnership with the GPL/GPT. The GCH co-leads the Clinical Product Team (CPT) and has accountability for the clinical deliverables.

Accountabilities include:

• Along with the Global Product Leader, provide scientific strategies for clinical components of the TPP, TPC, CDP, and core labelling
• Accountable for the clinical parts of CPT deliverables
• Responsible for overall clinical and scientific content for the asset
• Work closely with the Clinical Operations lead and ensure the CPT rapidly implements new processes, systems and learning
• Perform medical prioritization of clinical activities within the clinical program
• Single-point accountable leader for the design, delivery and interpretation of clinical studies ensuring ethical and scientific integrity in compliance with AZ policies and Good Clinical Practice

Basic Qualifications

• Graduate of a recognized school of medicine with an M.D. degree or MBBS, with 5+ years proven experience in drug development.
• Demonstrated deep late-stage clinical and research expertise in Liver disease, preferably MASH.
• Delivered multiple complex and large studies (e.g., including but not limited to international outcome studies).
• Demonstrated success in influencing global and local cross-functional stakeholders.
• Experience assessing the benefit/risk profile of an asset and creating patient risk management plans.
• Experience with global regulatory submissions and interacting with major regulatory agencies.

When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.

As AstraZeneca continues to put patients at the forefront of our mission, we are excited for our move to Kendall Square/Cambridge in 2026. 

Find out more information here:    

Kendall Square Press Release

Where can I find out more?

CVRM at AstraZeneca: https://www.astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism.html

Life at AstraZeneca : https://careers.astrazeneca.com/inclusion-diversity

Why AstraZeneca?

AstraZeneca is a global, innovation-driven biopharmaceutical company proud to provide a unique workplace culture that inspires innovation and cross-boundary collaboration. Within this environment employees are empowered to express diverse perspectives, and are made to feel valued, energized and rewarded for their ideas and creativity. There’s no better place to see what science can do.